Home › NDC Lookup › RxCUI directory › RxCUI 1299896

Moexipril hydrochloride 15 MG Oral Tablet — RxCUI 1299896

RxNorm drug concept · Semantic clinical drug
RxCUI 1299896 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1299896
Official nameMoexipril hydrochloride 15 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmoexipril HCl 15 MG Oral Tablet
FDA products mapped6
Package NDCs mapped10
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Moexipril: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Moexipril is used to treat high blood pressure (hypertension). It can be used on its own or alongside a diuretic (water pill) if blood pressure isn't controlled well enough with mo...
  • Yes, timing really matters here. You should take moexipril on an empty stomach, about one hour before a meal. Food — especially a high-fat meal — can reduce how much of the drug yo...
  • Does it matter when I take moexipril — can I take it with food?
  • Yes, a dry, persistent cough is the most common reason people stop taking moexipril. It happens because ACE inhibitors affect a chemical called bradykinin in your airways. It's ann...
📖 Read our full Moexipril guide →

🕸️ Concept Web — How Moexipril hydrochloride 15 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Moexipril hydrochloride 15 MG Oral Tablet RxCUI 1299896

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Moexipril 30131
    • Moexipril hydrochloride 236066
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Moexipril Oral Tablet 372945
    • Moexipril hydrochloride Oral Tablet 2647546
    • Moexipril Oral Product 1157288
    • Moexipril Pill 1157289
    • Moexipril hydrochloride Oral Product 2660465
    • Moexipril hydrochloride Pill 2660648
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Moexipril hydrochloride 15 MG 1299858

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Moexipril hydrochloride 15 MG SCDC · 1299858
  • Moexipril Oral Tablet SCDF · 372945
  • Moexipril hydrochloride Oral Tablet SCDFP · 2647546
  • Moexipril Oral Product SCDG · 1157288
  • Moexipril Pill SCDG · 1157289
  • Moexipril hydrochloride Oral Product SCDGP · 2660465
  • Moexipril hydrochloride Pill SCDGP · 2660648

📦 FDA Products & Package NDCs

6 products · 10 package NDCs
10 package NDCs map to RxCUI 1299896 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-0017-01 100 TABLET, FILM COATED in 1 BOTTLE (0093-0017-01) Moexipril Hydrochloride Teva Pharmaceuticals USA, Inc. 2003-05-08
00093-5150-01 100 TABLET, FILM COATED in 1 BOTTLE (0093-5150-01) Moexipril Hydrochloride Teva Pharmaceuticals USA, Inc. 2003-05-08
62135-0967-90 90 TABLET, FILM COATED in 1 BOTTLE (62135-967-90) Moexipril Hydrochloride Chartwell RX, LLC 2025-03-05
62135-0969-90 90 TABLET, FILM COATED in 1 BOTTLE (62135-969-90) Moexipril Hydrochloride Chartwell RX, LLC 2025-03-05
68462-0208-01 100 TABLET, FILM COATED in 1 BOTTLE (68462-208-01) Moexipril Hydrochloride Glenmark Pharmaceuticals Inc., USA 2010-12-31
68462-0208-10 1000 TABLET, FILM COATED in 1 BOTTLE (68462-208-10) Moexipril Hydrochloride Glenmark Pharmaceuticals Inc., USA 2010-12-31
68462-0208-90 90 TABLET, FILM COATED in 1 BOTTLE (68462-208-90) Moexipril Hydrochloride Glenmark Pharmaceuticals Inc., USA 2010-12-31
68462-0209-01 100 TABLET, FILM COATED in 1 BOTTLE (68462-209-01) Moexipril Hydrochloride Glenmark Pharmaceuticals Inc., USA 2010-12-31
68462-0209-10 1000 TABLET, FILM COATED in 1 BOTTLE (68462-209-10) Moexipril Hydrochloride Glenmark Pharmaceuticals Inc., USA 2010-12-31
68462-0209-90 90 TABLET, FILM COATED in 1 BOTTLE (68462-209-90) Moexipril Hydrochloride Glenmark Pharmaceuticals Inc., USA 2010-12-31
Observed labelers: Glenmark Pharmaceuticals Inc., USA (6) · Chartwell RX, LLC (2) · Teva Pharmaceuticals USA, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.